Papa Murphy's Holdings (FRSH) PT Lowered to $5 at Jefferies; Remains Sidelined
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
After-Hours Stock Movers 05/10: (SGMO) (RELY) (PEGA) Higher; (NH) (SNAP) (MNKD) Lower (more...)
May 10, 2017 6:25 PM EDTToday's After-Hours Movers
Sangamo Therapeutics, Inc. (Nasdaq: SGMO) 39% HIGHER; Sangamo and Pfizer Inc. (NYSE: PFE) today announced an exclusive, global collaboration and license agreement for the development and commercialization of gene therapy programs for Hemophilia A, including SB-525, one of Sangamo's four lead product candidates, which Sangamo expects will enter the clinic this quarter.
NantHealth (NASDAQ: NH) 24% LOWER; reported Q1 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20). Revenue for the quarter... More
Papa Murphy's (FRSH) Misses Q1 EPS by 25c, Miss on Revenues; Increases FY17 Cash FLlow Outlook
May 10, 2017 4:12 PM EDTPapa Murphy's (NASDAQ: FRSH) reported Q1 EPS of ($0.32), $0.25 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $32 million versus the consensus estimate of $35.21 million.
... More
